Stocks and Investing Stocks and Investing
Thu, September 8, 2022

Marc Goodman Maintained (AMLX) at Buy with Increased Target to $50 on, Sep 8th, 2022


Published on 2024-10-27 22:56:18 - WOPRAI, Marc Goodman
  Print publication without navigation


Marc Goodman of SVB Leerink, Maintained "Amylyx Pharmaceuticals, Inc." (AMLX) at Buy with Increased Target from $31 to $50 on, Sep 8th, 2022.

Marc, nor any peers, have made any analyst calls on AMLX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources